|
2015
|
Invention
|
New salt of abexinostat, associated crystalline form, a process for their preparation and pharmac... |
|
|
Invention
|
Inhibitors of bruton's tyrosine kinase.
Described herein are irreversible kinase inhibitor compo... |
|
|
Invention
|
Intracellular kinase inhibitors.
Intracellular kinase inhibitors and their therapeutic uses for ... |
|
|
Invention
|
Biomarkers for predicting response of dlbcl to treatment with ibrutinib.
Described herein are di... |
|
|
Invention
|
Formulations of histone deacetylase inhibitor and uses therof.
Dosing regimens, methods of treat... |
|
|
Invention
|
Inhibitors of bruton's tyrosine kinase.
Disclosed herein are compounds that form covalent bonds ... |
|
2014
|
Invention
|
Methods of treating and preventing alloantibody driven chronic graft versus host disease.
Descri... |
|
|
Invention
|
Treatment using bruton's tyrosine kinase inhibitors and immunotherapy.
Combinations of Bruton's ... |
|
|
Invention
|
Selective inhibitors of histone deactylase.
Described herein are compounds and pharmaceutical co... |
|
|
Invention
|
Uses of selective inhibitors of hdac8 and treatment of inflammatory conditions.
Described herein... |
|
|
Invention
|
Administration regime for n-hydroxy-4-benzamide.
N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benz... |
|
|
Invention
|
Use of inhibitors of bruton's tyrosine kinase (btk). Disclosed herein are methods for treating a ... |
|
|
Invention
|
Crystalline forms of a bruton's tyrosine kinase inhibitor.
Described herein is the Bruton's tyro... |
|
|
Invention
|
Novel hydroxamates as therapeutic agents.
The present invention is directed to certain hydroxama... |
|
|
Invention
|
Salt of abexinostat, associated crystalline form, a process for their preparation and pharmaceuti... |
|
|
Invention
|
Use of inhibitors of bruton's tyrosine kinase (btk).
Disclosed herein are methods for treating a... |
|
|
Invention
|
Inhibitors of bruton's tyrosine kinase. Disclosed herein are compounds that form covalent bonds w... |
|
2013
|
Invention
|
Inhibitors of bruton's tyrosine kinase.
Described herein are kinase inhibitor compounds, methods... |
|
|
Invention
|
Pyrrolopyrimidine compounds as kinase inhibitors. Disclosed herein are compounds exemplified by t... |
|
|
Invention
|
Pyrrolopyrimidine compounds as kinase inhibitors. Disclosed herein are compounds that form covale... |
|
|
Invention
|
Inhibitors of bruton's tyrosine kinase. Disclosed herein are compounds of Formula (A) that form c... |
|
|
Invention
|
Tec family kinase inhibitor adjuvant therapy. Described herein are methods and compositions compr... |
|
|
Invention
|
Companion diagnostics for tec family kinase inhibitor therapy.
The invention provides methods, a... |
|
|
Invention
|
Companion diagnostics for tec family kinase inhibitor therapy. The invention provides methods, as... |
|
|
Invention
|
Manufacture, compositions and uses of coagulation factor viia modulator.
Treatment of cancer and... |
|
|
Invention
|
Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors. Described herein are ir... |
|
|
Invention
|
Mutations associated with resistance to inhibitors of bruton's tyrosine kinase (btk). Described h... |
|
|
Invention
|
Crystalline forms of a bruton's tyrosine kinase inhibitor. Described herein is the Bruton's tyros... |
|
|
Invention
|
Selective inhibitors of histone deacetylase. Described herein are compounds and pharmaceutical co... |
|
|
Invention
|
Inhibitors of bruton's tyrosine kinase. Described herein are kinase inhibitor compounds, methods ... |
|
|
Invention
|
Bruton's tyrosinie kinase activity probe and method of using.
Described herein are probes for Br... |
|
|
Invention
|
Inhibitors of bruton's tyrosine kinase. Disclosed herein are pyrazolo[3,4-d]pyrimidines that form... |
|
|
Invention
|
Combinations of histone deacetylase inhibitor and pazopanib and uses thereof.
Dosing regimens, m... |
|
|
Invention
|
Combinations of histone deacetylase inhibitor and pazopanib and uses thereof. Dosing regimens, me... |
|
2012
|
Invention
|
Cinnamic acid hydroxyamides as inhibitors of histone deacetylase 8.
Described herein are compoun... |
|
|
Invention
|
Use of inhibitors of bruton's tyrosine kinase (btk).
Methods are provided for treating a hematol... |
|
|
Invention
|
Factor viia inhibitor. The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa... |
|
|
Invention
|
Association between n-hydroxy-4-benzamide and folfox.
Association between N-hydroxy-4-{2-[3-(N,N... |
